VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CAPR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CAPRCapricor Therapeutics, Inc.
$8.95$515M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCAPRQuarterly Financials

Capricor Therapeutics, Inc. (CAPR) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Capricor Therapeutics, Inc. (CAPR) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CAPR Income Statement

Quarterly statement

CAPR Income Statement

Capricor Therapeutics, Inc. (CAPR) annual income statement — 27-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue00000011.13M2.26M3.97M4.91M12.09M6.19M3.92M2.99M959.9K1.59M0000
Revenue Growth %---100%-100%-100%-100%-7.92%-63.44%1.38%64.29%1159.3%288.66%-----100%-100%-100%-100%
Cost of Goods Sold00020.36M22.05M18.92M14.55M11.81M12.5M11.1M9.94M000000000
COGS % of Revenue------130.77%522.09%314.87%226.23%82.23%---------
Gross Profit000-20.36M-22.05M-18.92M-3.42M-9.55M-8.53M-6.19M2.15M6.19M3.92M2.99M959.9K1.59M0000
Gross Margin %-------30.77%-422.09%-214.87%-126.23%17.77%100%100%100%100%100%----
Gross Profit Growth %100%100%100%-113.27%-158.37%-205.38%-259.43%-254.32%-317.83%-307.39%123.76%288.66%-----100%-100%100%100%
Operating Expenses42.95M36.77M29.16M5.92M5.67M6.07M4.27M3.46M3.06M4.07M3.43M13.05M11.66M11.17M9.03M8.07M7.32M7.83M6.38M4.31M
OpEx % of Revenue------38.39%153.15%77%82.98%28.37%210.97%297.76%374.04%940.33%507%----
Selling, General & Admin14.08M9.14M6.02M5.92M5.67M6.07M4.27M3.46M3.06M4.07M3.43M2.91M2.75M3.42M2.79M2.56M2.36M2.72M2.12M1.8M
SG&A % of Revenue------38.39%153.15%77%82.98%28.37%47.01%70.2%114.43%291.12%161.16%----
Research & Development28.87M27.38M23.13M20.36M22.05M18.92M14.55M11.81M12.5M11.1M9.94M10.03M8.82M7.66M6.23M5.5M4.97M5.12M4.26M2.51M
R&D % of Revenue------130.77%522.09%314.87%226.23%82.23%162.13%225.08%256.52%649.21%345.85%----
Other Operating Expenses0253.35K0-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K113.68K97.3K92.35K000000
Operating Income-42.95M-36.77M-29.16M-26.28M-27.72M-24.98M-7.7M-13.01M-11.59M-10.27M-1.28M-6.86M-7.75M-8.18M-8.07M-6.48M-7.32M-7.83M-6.38M-4.31M
Operating Margin %-------69.16%-575.24%-291.86%-209.21%-10.6%-110.97%-197.76%-274.04%-840.33%-407%----
Operating Income Growth %-54.93%-47.19%-278.78%-102.03%-139.14%-143.36%-500.79%-89.52%-49.62%-25.43%84.12%-5.97%-5.81%-4.51%-26.44%-50.14%-44.04%-51.74%-52.6%-10.23%
EBITDA252.94M-36.24M974.21M-25.79M-27.23M-24.58M-7.32M-12.65M-11.23M-9.93M-973.68K-6.59M-7.49M-7.95M-7.87M-6.34M-7.21M-7.74M-6.3M-4.25M
EBITDA Margin %-------65.78%-559.27%-282.88%-202.46%-8.05%-106.5%-191.26%-266.33%-820.37%-398.4%----
EBITDA Growth %1028.81%-47.44%13404.96%-103.89%-142.41%-147.4%-652%-91.99%-49.94%-24.89%87.64%-3.9%-3.92%-2.79%-24.98%-49.2%-43.31%-51.42%-52.25%-9.59%
D&A (Non-Cash Add-back)295.89M534.67K1B494.73K486.28K405.45K375.7K361.17K356.94K331.41K307.61K276.47K254.7K230.1K191.6K137.03K112.01K92.49K78.64K64.72K
EBIT-40.73M-33.94M-27.13M-24.57M-25.91M-24.39M-7.12M-12.56M-11M-9.79M-762.09K-6.86M-7.75M-8.18M-8.07M-6.48M-7.32M-7.83M-6.38M-4.31M
Net Interest Income2.21M2.9M-1.02M1.71M1.79M729.54K686.57K453.15K591.44K471.83K233.93K000000000
Interest Income2.21M2.9M2.02M1.71M1.79M729.54K686.57K453.15K591.44K471.83K233.93K000000000
Interest Expense003.05M00000000000000000
Other Income/Expense2.21M2.83M-1.01M1.71M1.81M591.35K581.24K453.15K591.44K471.83K519.2K473.99K380.68K416.44K345.43K106.64K212.34K13.44K189.12K382.74K
Pretax Income-40.73M-33.94M-30.17M-24.57M-25.91M-24.39M-7.12M-12.56M-11M-9.79M-762.09K-6.39M-7.37M-7.77M-7.72M-6.37M-7.11M-7.82M-6.19M-3.93M
Pretax Margin %-------63.94%-555.2%-276.97%-199.6%-6.3%-103.31%-188.04%-260.1%-804.34%-400.3%----
Income Tax1.6K0000000000000000000
Effective Tax Rate %-0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-40.73M-33.94M-30.17M-24.57M-25.91M-24.39M-7.12M-12.56M-11M-9.79M-762.09K-6.39M-7.37M-7.77M-7.72M-6.37M-7.11M-7.82M-6.19M-3.93M
Net Margin %-------63.94%-555.2%-276.97%-199.6%-6.3%-103.31%-188.04%-260.1%-804.34%-400.3%----
Net Income Growth %-57.21%-39.15%-323.95%-95.68%-135.56%-149.04%-833.83%-96.49%-49.32%-26.08%90.13%-0.31%-3.62%0.64%-24.72%-62.04%-49.73%-51.75%-48.17%-0.55%
Net Income (Continuing)-40.73M-33.94M-30.17M-24.57M-25.91M-24.39M-7.12M-12.56M-11M-9.79M-762.09K-6.39M-7.37M-7.77M-7.72M-6.37M-7.11M-7.82M-6.19M-3.93M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.70-0.59-0.62-0.54-0.57-0.53-0.16-0.38-0.35-0.31-0.02-0.25-0.29-0.31-0.31-0.26-0.29-0.32-0.26-0.17
EPS Growth %-22.81%-11.32%-287.5%-42.11%-62.86%-70.97%-542.57%-52%-20.69%0%91.97%3.85%0%3.13%-19.23%-52.94%-38.1%-39.13%-23.81%15%
EPS (Basic)-0.70-0.59-0.62-0.54-0.57-0.53-0.16-0.38-0.35-0.31-0.02-0.25-0.29-0.31-0.31-0.26-0.29-0.32-0.26-0.17
Diluted Shares Outstanding57.93M57.43M48.85M45.72M45.71M45.64M35.22M33.09M31.84M31.36M26.78M25.82M25.34M25.25M25.16M24.43M24.32M24.28M24.15M23.1M
Basic Shares Outstanding57.93M57.43M48.85M45.72M45.71M45.64M35.22M33.09M31.84M31.36M26.78M25.82M25.34M25.25M25.16M24.43M24.32M24.28M24.15M23.1M
Dividend Payout Ratio--------------------